64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab

NCT01006226 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn due to funding issues

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: 64Cu-ATSM PET

Sponsor

Washington University School of Medicine